Affiliation:
1. Institute for Advanced Pharmaceutical Materials Asymchem Life Sciences (Tianjin) Co., Ltds. No. 265, South Avenue, TEDA West Tianjin 300301 P. R. China
Abstract
AbstractMany macrocyclic compounds are attractive drug‐like molecules or intermediates due to their special properties. However, the bulk synthesis of such compounds are hindered by the necessity of using diluted solutions, in order to prevent intermolecular reactions that yields oligomer impurities, thereby resulting in a low production efficiency. Such challenge can be adequately addressed by using continuous reactors, allowing improved efficiency with smaller space footprints. In this work, we proposed a novel continuous process for the synthesis of a macrocyclic sulfite of tetraethylene glycol (PEG4‐MCSi), which is a precursor to a very useful building block, PEG4‐macrocyclic sulfate (PEG4‐MCS). The basic reaction parameters, including stoichiometry and temperature, were first confirmed with small batch reactions, and the effectiveness of coiled reactors and continuous stirred tank reactors (CSTRs) were compared. Cascaded CSTRs were proven to be suitable, and the reaction parameters were subject to further optimization to give a robust continuous process. The process was then tested with 4 parallel runs for up to 64 h. Finally, the merits and demerits of batch and continuous reactions were also compared, demonstrating the suitability of latter in the bulk production of macrocyclic PEG‐MCSi compounds.